Last update :
18/04/2024
References   References 2594  
Type : Journal

Research teams : Vancouver - Children\'s and Women\'s Health Center of British Columbia
Authors : Ensom MHH, Decarie D, Sheppard I.
Title : Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration.
Reference : Can J Hosp Pharm ; 60, 3: 184-191. 2007

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
Oral solutionLansoprazole Proton pump inhibitor
Stability in solutions Glass Kapseln 150 mg
®=? (Abbott Laboratories)
NaHCO3 8.4% >> 50 ml
25°C Light
91 Day
Stability in solutions Glass Kapseln 150 mg
®=? (Abbott Laboratories)
NaHCO3 8.4% 25 ml
NaOH 1N = 1.7 ml
OraPlus® / OraSweet® (1:1) 23.3 ml
PH= 8.4
25°C Light
91 Day
Stability in solutions Glass Kapseln 150 mg
®=? (Abbott Laboratories)
NaHCO3 8.4% >> 50 ml
4°C Protect from light
91 Day
Stability in solutions Glass Kapseln 150 mg
®=? (Abbott Laboratories)
NaHCO3 8.4% 25 ml
NaOH 1N = 1.7 ml
OraPlus® / OraSweet® (1:1) 23.3 ml
PH= 8.4
4°C Protect from light
91 Day

  Mentions Légales